Replies to post #2752 on Momenta Pharmaceuticals, Inc. (MNTA)

[IB2011]

Totally agreed. The secondary offering made zero economic sense.

[jbog]

Rocky3,

management should not have included an offering last fall. It was evidence of economic weakness at the time, not strength.

I couldn't agree with you more. CW could have said at numerous conferences that MNTA saw no need to raise cash because he didn't see T-Enox on the immediate horizon. Instead they claimed some garbage about a FOB program, gave expense rates for a year out (which contradicted and big spend program) and continued to rake in the M-Enox cash.

The whole transaction made no sense, so investor's had to side with the safest assumption which would have been that T-Enox was coming.

[Bio_pete]

"I stand with my view that it was a bad management decision, and hurt the company (not just the stock price) more than it helped it. As a holder of the stock for the long term (or any seasoned investor), one would be hard pressed to see it any other way."

How about having a little more patience. In case you haven't noticed MNTA's stockprice is quickly recovering. Does anyone think the stock would be trading higher if they didn't have the additional $100 mil in the bank?